ArticleScientific reports2024

Lidocaine inhibits the lung cancer progression through decreasing the HIST1H2BL levels via SIRT5 mediated succinylation.

Xuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.